Octreotide implant having a release agent

Details for Australian Patent Application No. 2009262263 (hide)

Owner Endo Pharmaceuticals Solutions Inc.

Inventors Kuzma, Petr; Quandt, Harry; Decker, Stefanie

Agent FB Rice

Pub. Number AU-A-2009262263

PCT Pub. Number WO2009/158415

Priority 61/075,625 25.06.08 US; 61/080,144 11.07.08 US

Filing date 24 June 2009

Wipo publication date 30 December 2009

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 38/31 (2006.01) Medicinal preparations containing peptides - Somatostatins

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61P 5/08 (2006.01) Drugs for disorders of the endocrine system

Event Publications

27 January 2011 PCT application entered the National Phase

  PCT publication WO2009/158415 Priority application(s): WO2009/158415

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009262265-Generating retail sales report

2009262258-Cosmetic package with integrally molded wiper